ALEXANDRIA, Va., June 4 -- United States Patent no. 12,318,409, issued on June 3, was assigned to SEOUL NATIONAL UNIVERSITY R & DB FOUNDATION (Seoul, South Korea).
"Pharmaceutical composition for promoting osteogenesis, comprising osteoblast-derived mitochondria" was invented by Yun-Sil Lee (Seoul, South Korea), Na-Kyung Kim (Seoul, South Korea) and Joonho Suh (Seoul, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a pharmaceutical composition for promoting osteogenesis and a pharmaceutical composition for treating bone diseases, the compositions comprising osteoblast-derived mitochondria as an active ingredient."
The patent was filed on May 29, 2020, under Applic...